27 Jun Commercialization of COVID-19 Vaccine
Commercialization of COVID-19 Vaccine
COVID-19 vaccine will soon be available for purchase on the commercial market and will be available to order through the Vaccines for Children (VFC) Program. We do not have an exact date or timeline for commercialization, but we want to provide as much lead time as we can for our VFC providers about this upcoming change.
Commercialization of COVID-19 vaccines will transition vaccines previously purchased by the U.S. government to established pathways of procurement, distribution, and payment by both public and private payers.
What does this mean?
There will not be a separate COVID-19 Provider Program as currently exists.
- All VFC providers will be required to maintain a supply of COVID-19 vaccine for the entire patient population they serve. As with other ACIP recommended vaccines, your practice will need to stock COVID-19 vaccine for both VFC eligible children and privately insured patients once commercialization occurs.
Why is this important?
- COVID-19 vaccine is an ACIP-recommended vaccine and has been added to the CDC Child and Adolescent Immunization Schedule.
- Your patients may not have access to COVID-19 vaccine elsewhere. Pharmacies are not authorized to vaccinate kids under 3 years of age, so your practice may be the only place your patients can get vaccinated.
- A very low percentage (<20%) of kids 6 months – 4 years have been vaccinated against COVID-19 in Philadelphia, which means they may not be protected against severe disease and death from COVID-19.
Did you know?
- You don’t need an ultra-low freezer to store COVID-19 vaccine! You can store COVID-19 vaccines in your regular storage units.
- Providers should never turn down an opportunity to vaccinate for COVID-19 due to fears of vaccine wastage! We expect smaller packaging sizes of vaccine to be available this fall with commercialization.
Please be on the lookout for updated messages from the Immunization Program about commercialization throughout the summer. Have questions or concerns? Direct them to vaccines@phila.gov.